Skip to content

Clinical trials

Observational Prostatic Neoplasms trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Observational Country / region: Switzerland Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20093
20103
20111
20131
20142
20151
20161
20172
20202
20212
20221
20231
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting7
Active, not recruiting3
Not yet recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Zurich4
University of Lausanne Hospitals3
Insel Gruppe AG, University Hospital Bern2
Oncology Institute of Southern Switzerland2
Swiss Cancer Institute2
Bayer1
Clinica Luganese Moncucco1
Ferring Pharmaceuticals1
Heinrich-Heine University, Duesseldorf1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms27
Breast Neoplasms3
Neoplasms3
Urinary Bladder Neoplasms2
Adenocarcinoma1
Anorexia1
Bile Duct Neoplasms1
Body Weight Changes1
Brain Neoplasms1
Breast Neoplasms, Male1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.